-
3 Reasons Bristol-Myers Could Become One Of The Best Investments Of The Next 5 Years
Post on 4/9/19
-
Horizon Technology Finance Provides $20 Million Venture Loan Facility to Encore Dermatology
Post on 4/8/19
-
Pulmatrix Closes $16.6 Million Upsized Public Offering
Post on 4/8/19
-
T2 Biosystems Reports Granting of Inducement Awards
Post on 4/8/19
-
Homology Medicines Announces Proposed Public Offering of Common Stock
Post on 4/8/19
-
Here's Why Syros Pharmaceuticals Is Collapsing Today
Post on 4/8/19
-
Should Biogen Investors Be Extra Nervous Right Now?
Post on 4/8/19
-
Why Abiomed Stock Fell 15% in March
Post on 4/8/19
-
I-Mab Biopharma and Jiangsu Nhwa Pharmaceutical Announce Strategic Collaboration Agreement with Biodextris
Post on 4/7/19
-
Syros Prices $70M Concurrent Public Offerings
Post on 4/7/19
-
Why Biogen Stock Tanked in March
Post on 4/5/19
-
1 Biotech That Biogen Should Buy ... but Probably Won't
Post on 4/5/19
-
AquaBounty Technologies Prices of $5.75M Public Offering of Common Stock
Post on 4/4/19
-
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post on 4/4/19
-
Syros Announces Proposed Concurrent Public Offerings of Common Stock
Post on 4/4/19
-
Catapult and Smithwise To Merge
Post on 4/4/19
-
Pulmatrix Prices $14.4 Million Upsized Public Offering
Post on 4/3/19
-
AVEO Pharmaceuticals Announces Proposed Public Offering
Post on 4/3/19
-
Aileron Therapeutics Completes $26M Private Placement
Post on 4/3/19
-
Chiasma Closes $34.5M Offering of Common Stock
Post on 4/3/19
-
Editas Medicine and BlueRock Therapeutics Enter Strategic Research Collaboration
Post on 4/3/19
-
Blueprint Medicines Announces Closing of Public Offering
Post on 4/2/19
-
Fusion Pharmaceuticals Raises $105 Million in Oversubscribed Series B Financing
Post on 4/2/19
-
Lantheus Enters Strategic Collaboration with Cerevast
Post on 4/2/19
-
What's Wrong With Sarepta Therapeutics?
Post on 4/2/19